Massive estrogen therapy: phase I study of hexestrol (NSC-9894).
D000818:Animals; D000970:Antineoplastic Agents / Q000633:toxicity*; D004285:Dogs; D005260:Female; D000882:Haplorhini; D006589:Hexestrol / Q000633:toxicity*; D006801:Humans; D008297:Male; D051379:Mice; D051381:Rats
D000970:Antineoplastic Agents; D006589:Hexestrol